CAS 142715-48-8

4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride

Description:

4-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-quinazolinamine monohydrochloride, with CAS number 142715-48-8, is a synthetic compound characterized by its complex molecular structure, which includes isoquinoline and quinazoline moieties. This compound typically exhibits properties associated with its heterocyclic nature, such as potential biological activity, including anti-cancer or neuroprotective effects, although specific pharmacological data may vary. The presence of multiple methoxy groups suggests enhanced lipophilicity, which may influence its solubility and permeability in biological systems. As a hydrochloride salt, it is likely to be more soluble in water compared to its free base form, facilitating its use in pharmaceutical formulations. The compound's intricate structure may also contribute to its specificity in interacting with biological targets, making it a subject of interest in medicinal chemistry research. However, detailed studies are necessary to fully elucidate its pharmacodynamics and pharmacokinetics.

Formula: C₃₁H₃₇ClN₄O₆

Synonyms:

• CP-100356 Monohydrochloride
• 4-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-N-[2-(3,4-diMethoxyphenyl)ethyl]-6,7-diMethoxy-2-quinazolinaMine Monohydrochloride

CP 100,356 (hydrochloride)

CAS: 142715-48-8

Formula: C₃₁H₃₇ClN₄O₆

Purity: 95%

Color and Shape: Solid

Molecular weight: 597.1017

Ref: IN-DA009FSD

CP-100356 hydrochloride

CAS: 142715-48-8

CP-100356 hydrochloride

Purity: ≥98%

Molecular weight: 597.1g/mol

Ref: 54-BUP21836

CP-100356 monohydrochloride

CAS: 142715-48-8

Formula: C₃₁H₃₆N₄O₆·HCl

Molecular weight: 597.10

Ref: 7W-GK8865

CP-100356 monohydrochloride

CAS: 142715-48-8

CP-100356 monohydrochloride is a tyrphostin that selectively inhibits the phosphatidylinositol 3-kinase (PI3K) enzyme. Tyrphostins are small molecules that act as potent inhibitors of the PI3K family of enzymes, which regulate cellular proliferation and survival. CP-100356 monohydrochloride has been shown to inhibit cell growth in vitro and to induce autophagy, which helps cells survive under stress conditions. CP-100356 monohydrochloride has been studied in clinical trials for pediatric patients with myeloid leukemia. Patients who were treated with CP-100356 monohydrochloride had improved prognosis compared to those who received chemotherapy alone or other tyrosine kinase inhibitors.

Formula: C₃₁H₃₆N₄O₆·HCl

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 597.1 g/mol

Ref: 3D-SFA71548

CP-100356 hydrochloride

CAS: 142715-48-8

CP-100356 hydrochloride is an MDR1 (P-gp) and BCRP inhibitor, a nucleotide-derived substrate analog that induces stomatal opening in the dark.

Formula: C₃₁H₃₇ClN₄O₆

Purity: 99.19%

Color and Shape: Solid

Molecular weight: 597.1

Ref: TM-T22680